Global Single-use Bioprocessing Market Opportunities and Forecast 2023-2030

Single-use Bioprocessing Market Overview

The global Single-use Bioprocessing market is mainly driven due to the increasing expiry of patents of blockbuster molecules and rising demand for biologics. Increasing acceptance of single-use technologies in manufacturing processes and technological advancements boost the growth of the single-use bioprocessing market. As well, the ability of customers to make changes and order single-use product as per their customization also fuel the growth of the single-use bioprocessing market in the coming years. In addition to this, bioreactors and single-use bags and containers are all open to customer-specific requirements, depending on the type of application.

Furthermore, the aging population has been rising across the world. According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The aging population is more prone to diseases such as hypertension, chronic kidney diseases diabetes, cardiovascular diseases, and cancer as they have less immunity. Hence, the rising aging population is also a major factor for the upsurge in the growth of the single-use bioprocessing market in the forthcoming years.

Moreover, the number of therapeutic antibody candidates in phase 3 clinical development in the U.S. has increased to over 50 in the past five years. Single-use technologies are being rapidly adopted in these application areas. Thus, growth in monoclonal antibody production and vaccine production is projected to enlarge the single-use bioprocessing market in the forecast period.

Covid-19 Impact on Single-use Bioprocessing Market:

In addition, the current Single-use Bioprocessing Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Single-use Bioprocessing Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Single-use Bioprocessing Market Segment Overview

The highest penetration of Filtration Devices, Tubing, Sampling Systems, and Connectors & Clamps, in terms of product availability and usage, has impacted more to the revenue generation in the market. In addition to this, advancements in the single-use system have prompted bioprocess engineers to replace their fixed piping networks with single-use transfer lines. Besides this, the demand for disposable probes and sensors is continuously increasing within the biopharmaceutical industry. This demand is found to be high across the U.S. and Europe. Additionally, the emerging and small players are involved in gaining a competitive edge in this segment by offering single-use sensors for the measurement of multiple attributes during bioprocessing.

Single-use Bioprocessing Market, By Product

·       Bioreactors & Fermenters
·       Mixers
·       Bags 
·       Bioprocess Containers
·       Filtration Devices
·       Tubing
·       Sampling Systems
·       Connectors & Clamps
·       Probes & Sensors

Single-use Bioprocessing Market, By Application

·       Monoclonal Antibody Production
·       Vaccine Production
·       Plant Cell Cultivation
·       Patient Specific Cell Therapies
·       Others

Single-use Bioprocessing Market, By End-User

·       Pharmaceutical Companies
·       Biotechnology Companies
·       Cros & Cmos
·       Academic & Research Institutes

Single-use Bioprocessing Market Regional Overview

Region-wise, North America dominated the single-use bioprocessing market in 2020. This can be attributed to the increasing biopharmaceutical R&D coupled with the presence of large-scale biopharmaceutical manufacturing facilities in the U.S. has largely contributed to the market’s growth in this region. Similarly, the Asia Pacific is expected to register the fastest growth during the forecast period. In recent years, China has emerged as a potential market for single-use technology with the growing biopharmaceutical manufacturing industry.

Single-use Bioprocessing Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Single-use Bioprocessing Market Competitor overview

Some key developments and strategies adopted by manufacturers in Single-use Bioprocessing are highlighted below.

·       In June 2021, Antylia ScientificTM, a global frontrunner in peristaltic and single use bioprocessing solutions and with a wide range of analytical and measurement products for the environmental, pharmaceutical, biopharma, and healthcare sectors, has recently burst onto the scene of the analytical instrumentation market. Antylia Scientific aims to build on the cornerstones of innovative products and solutions and specialist support for their clientele by increasing their organic product R&D capacity, as well as the acquisition of companies that offer outstanding products to enhance and expand their portfolio. 

Single-use Bioprocessing Market, Key Players

·       Danaher Corporation
·       Eppendorf AG
·       Meissner Filtration Products, Inc.
·       Parker Hannifin Corporation
·       PBS Biotech, Inc
·       Thermo Fisher Scientific, Inc
·       GE Healthcare (General Electric Company)
·       Merck KGaA
·       Saint-Gobain
·       Sartorius AG